Svas Biosana is an Italian company specialized in the healthcare sector, active in the production and distribution of medical devices for public and private healthcare facilities.
Our equity research confirms the BUY and maintains the Target Price at €17.
Find out why in the analysis by Francesca Romana Sabatini Head of Equity Research and Michele Calusa Equity Research Analyst.
